Koh, S., Tham, K., Razvi, K., Oei, P., Lim, F., Roy, A., . . . GYNAECOLOGY, O. &. (2016). Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: Could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome?
Chicago Style CitationKoh, S.C.L., K.-F Tham, K. Razvi, P.-L Oei, F.-K Lim, A.-C Roy, R.N.V Prasad, and OBSTETRICS & GYNAECOLOGY. Hemostatic and Fibrinolytic Status in Patients With Ovarian Cancer and Benign Ovarian Cysts: Could D-dimer and Antithrombin III Levels Be Included As Prognostic Markers for Survival Outcome? 2016.
MLA引文Koh, S.C.L., et al. Hemostatic and Fibrinolytic Status in Patients With Ovarian Cancer and Benign Ovarian Cysts: Could D-dimer and Antithrombin III Levels Be Included As Prognostic Markers for Survival Outcome? 2016.